Literature DB >> 7446724

Epitrochlearis muscle. II. Metabolic effects of contraction and catecholamines.

R Nesher, I E Karl, D M Kipnis.   

Abstract

Effects of isometric contraction and catecholamines on glucose and glycogen metabolism in skeletal muscle were investigated with the in vitro rat epitrochlearis preparation. Mechanical performance and glycogenolysis exhibited two phases. During the initial 30 min, muscle work was 30% greater and glycogenolysis 8- to 10-fold faster than the steady-state values in the subsequent 3-4 h of contraction. Glucose uptake was increased by contraction and remained relatively constant during stimulation. Epinephrine (10(-9) to 10(-6) M) and norepinephrine (10(-7) to 10(-5) M) produced inotropic and glycogenolytic effects blocked by propranolol but not phentolamine. Chemical sympathectomy and propranolol blocked the initial glycogenolytic and inotropic effects produced by isometric contraction, suggesting that they were caused by the release of endogenous catecholamines. Net lactate production in resting muscles accounted for > 50% of total glucosyl units utilized. During contraction net lactate production accounted < 10-15% of total glycosyl flux indicating that rat fast-twitch pale muscle is capable of significant rates of aerobic glucose oxidation. Oleate and caprylate did not affect mechanical performance, glycogen, or glucose metabolism in resting or contracting muscles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7446724     DOI: 10.1152/ajpendo.1980.239.6.E461

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Resistance exercise overtraining and overreaching. Neuroendocrine responses.

Authors:  A C Fry; W J Kraemer
Journal:  Sports Med       Date:  1997-02       Impact factor: 11.136

Review 2.  cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration.

Authors:  Rebecca Berdeaux; Randi Stewart
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-21       Impact factor: 4.310

3.  Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro.

Authors:  M E Young; G K Radda; B Leighton
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

4.  The rate of substrate cycling between fructose 6-phosphate and fructose 1,6-bisphosphate in skeletal muscle.

Authors:  R A Challiss; J R Arch; E A Newsholme
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

5.  Contraction-stimulated glucose transport in rat skeletal muscle is sustained despite reversal of increased PAS-phosphorylation of AS160 and TBC1D1.

Authors:  Katsuhiko Funai; Gregory D Cartee
Journal:  J Appl Physiol (1985)       Date:  2008-09-25

6.  A 31P-n.m.r. study of the acute effects of beta-blockade on the bioenergetics of skeletal muscle during contraction.

Authors:  R A Challiss; D J Hayes; G K Radda
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

7.  Dynamics of metabolic responses to prolonged elevation of circulating adrenaline in resting and exercising rats.

Authors:  K Nazar; H Kaciuba-Uściłko; S Porta; Z Brzezinska; J Langfort; W Pilis
Journal:  Pflugers Arch       Date:  1989-02       Impact factor: 3.657

8.  β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling.

Authors:  Robert A Ngala; Jacqueline F O'Dowd; Claire J Stocker; Michael A Cawthorne; Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-06       Impact factor: 3.000

9.  Muscle protein turnover and glucose uptake in acutely uremic rats. Effects of insulin and the duration of renal insufficiency.

Authors:  A S Clark; W E Mitch
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

10.  A myosin II ATPase inhibitor reduces force production, glucose transport, and phosphorylation of AMPK and TBC1D1 in electrically stimulated rat skeletal muscle.

Authors:  David R Blair; Katsuhiko Funai; George G Schweitzer; Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.